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Instructions to Authors
The ofﬁ cial journal of the Japanese College of Cardiology is an international, English language, peer-
reviewed journal publishing the latest ﬁ ndings in cardiovascular medicine. The Journal of Cardiology (JC) 
aims to publish the highest-quality material covering original basic and clinical research on all aspects of 
cardiovascular disease. Topics covered include ischemic heart disease, cardiomyopathy, valvular heart 
disease, vascular disease, hypertension, arrhythmia, congenital heart disease, pharmacological and non-
pharmacological treatment, new diagnostic techniques, and cardiovascular imaging. JC also publishes a 
selection of review articles, clinical trials, case reports, short communications, and important messages 
and letters to the editor.
 JC will receive materials prepared and submitted according to these instructions. However, we reserve 
the right to make any changes necessary to make the contribution conform to the editorial standards of 
the journal, as deemed by the Editorial Board based on the recommendations of the reviewers.
 Any contributions accepted for publication will become the copyright of this journal. No responsibility 
is assumed by the Editorial Board for the opinions or the ethics expressed by the contributors. The 
work shall not be published in any other publication in any language without prior written consent of the 
publisher.
Submission to JC now proceeds online via Elsevier Editorial System - http://ees.elsevier.com/jjcc. 
Authors will be guided step-by-step through uploading ﬁ les directly from their computers. Electronic PDF 
proofs will be automatically generated from uploaded ﬁ les, and used for subsequent reviewing.
Authors submitting hard copy papers will usually be asked to resubmit using Elsevier Editorial System. The 
Editor-in-Chief may occasionally allow hard copy submissions of some components of an article; please 
contact him should you consider this necessary, and send any such items to:
Editor-in-Chief, Journal of Cardiology
c/o Elsevier Japan, 1-9-15 Higashi-Azabu, Minato-ku, Tokyo 106-0044, Japan
Fax: Tel: +81-3-3589-6366
E-mail: jp.jjcc@elsevier.com
Global telephone support is available for e-submission 24/7:
A comprehensive Author Support service is also available to answer additional enquiries at
authorsupport@elsevier.com
For The Americas: +1 888 834 7287 (toll-free for US & Canadian customers)
For Asia & Paciﬁ c: +81 3 5561 5032
For Europe & rest of the world: +353 61 709190
Submission of manuscripts: Copyright
Submission of an article is understood to imply that the article is original and is not being considered 
for publication elsewhere. Upon acceptance of the article by the journal, the author(s) will be asked 
to transfer the copyright of the article to the publisher. This transfer will ensure the widest possible 
dissemination of information.
Multiple authorship
On submission, all authors of the paper listed should sign a letter in which they state that they all have 
participated sufﬁ ciently in the conception and design of the work, in the analysis of the data and in writing 
the manuscript to take public responsibility for it.
Ethical standards
Human subject experiments or the usage of human materials (such as tissues) should be in accordance 
with the ethical standards of a responsible committee at the institute where the research is carried out 
and with the Helsinki Declaration. Patients should be referred to by number; do not use real names, 
initials or hospital numbers. Animal studies should be carried out within recognised guidelines for the 
care of laboratory animals.
Material for publication
Original Articles
These may describe original clinical or laboratory research.
Reviews
Reviews may concern either clinical or laboratory scientiﬁ c topics. Relatively brief reviews of between 
2,500 and 3,000 words are particularly welcome. Longer reviews are acceptable when justiﬁ ed by topic 
and comprehensiveness.
Case Reports
A case report should describe a new disease, or conﬁ rmation of a rare or new disease; a new insight 
into pathogenesis, etiology, diagnosis, or treatment; or a new ﬁ nding associated with a currently known 
disease. A report of special scientiﬁ c investigation, even in a single patient, will be regarded as an original 
article. The length should ordinarily be less than 1,500 words, with no more than a total of 3 tables and 
ﬁ gures and 10 references. This can be exceeded only when justiﬁ ed by extensive special studies.
Letters to the Editor
These should be up to 1,000 words in length, and should be submitted in response to material published 
in the journal to make small clinical points or to introduce a point of view. They can be accompanied by 
up to 5 references but no illustrations.
Manuscript Format
Manuscripts should be written clearly in English. All manuscripts must be covered with a title page including 
the title (within 25 words), type of article and 3 to 6 keywords. The authors’ full and complete names, 
degrees, and institutions should be given on the title page, as well as full postal address, telephone/fax 
numbers, and e-mail address for correspondence.
Abstract
Brieﬂ y state the summary of the text within 300 words (Case Report: within 200 words, Letter to the 
Editors: within 120 words). The background and purpose, methods and subjects, essential results, and 
the principal conclusions should be included. The abstract may be re-published by information retrieval 
services in another forum.
Introduction
Clearly and brieﬂ y describe the background and the rational objective of the study, with a review of 
earlier publications. It is recommended that the previous studies described only be the most relevant. 
Avoid exhaustive review of the literature.
Materials and Methods/Case Histories
Clearly describe the subjects  and sample size, the experimental procedures and apparatus (manufacturer’s 
name and address) used in the study. In the case of experiments on human or animal subjects, give an 
account that the methods were regarded as ethically sound. In the event of an original design, the details 
should be provided. Otherwise, references accompanied by sufﬁ cient information for interdisciplinary 
evaluation will sufﬁ ce. The type of statistical analysis used must be stated in this section as well as 
the commercial software. Do not include discussion in this section. Demonstrate precisely all drugs and 
chemicals used, including generic names, doses and routes of administration.
Results
Present the essential results in the text in a clear and concise manner. Use tables and ﬁ gures to compare 
and contrast the ﬁ ndings. Do not repeat in the text all the detailed data in the tables or ﬁ gures. Do 
not include discussion in this section. In describing the statistical analysis, please deﬁ ne the probability 
values and prove that the differences reported were found to be statistically signiﬁ cant.
Discussion
Demonstrate the objective reliability of the results as well as the propriety and limitations of the experi-
mental procedures and subjects used. Point out the signiﬁ cance and the limitations of the study, including 
implications for future research. Describe and evaluate the results with a scientiﬁ cally critical view, and 
discuss your ﬁ ndings in the context of other publications, including opposing views. The introduction or 
the details of the results should not be repeated in this section. Subjective comments can be made only 
in this section, however, speculation must be identiﬁ ed as such. Link the conclusions with the objectives 
of the study, as stated in the introduction.
Acknowledgments
Acknowledgments, the scientiﬁ c meeting at which the data has already been presented, the sources of 
funding for the study, and/or any other special mention may be stated before the References section.
References
All publications cited in the text should be presented in a list of references following the text of the 
manuscript. References should be numbered consecutively in the order in which they are ﬁ rst mentioned. 
In the text they should be cited with Arabic numerals between square brackets. For listing references, 
follow the JAMA style, abbreviating names of journals according to Index Medicus. List all authors/editors 
but if there are more than ﬁ fteen, list ﬁ rst ﬁ fteen plus et al.
Examples:
[1]  Matsumura K, Kubota S, Serizawa T, Nakase E. Coronary hemodynamics in vasospastic angina: 
Quantitative analysis by digital subtraction angiography. J Cardiol 1991; 21: 507—516 (in Japanese).
[2]  Braunwald E: Pathology of pulmonary embolism. In: Braunwald E, editor. Heart disease: A textbook 
of cardiovascular medicine. 5th ed., Philadelphia: WB Saunders; 1997, p. 1582—1585.
Tables
Tables should be submitted online as a separate ﬁ le, bear a concise title, and be numbered with Arabic 
numerals. Tables should be cited in the text. Column headings should be brief, but sufﬁ ciently explana-
tory. Standard abbreviations of units of measurement should be added between parentheses. Vertical 
lines should not be used to separate columns.
Figures
Written permission must be obtained and supplied from the original author(s) and the original publisher 
(copyright holder) for the use of any ﬁ gures, charts, graphs, and tables previously published in other 
journals or books either by reproduction or with any modiﬁ cation. Credit must be given in legends and/or 
text for borrowed materials.
•  The number of ﬁ gures used to present data essential to illustrate or prove a point should be kept to 
a minimum.
•  Reference should be made in the text to each illustration. Figures will be reduced to ﬁ t to the size of 
one column (8.5 cm) or two columns (17.5 cm), and any lettering should be large enough to allow this 
reduction without becoming illegible
•  Each ﬁ gure should be accompanied by a title and an explanatory legend on a separate page called 
Legends to Figures. There should be sufﬁ cient experimental details in the legend to make the ﬁ gure 
intelligible without reference to the text
•  Legends to Figures should be typed double-spaced, in numerical order, on a separate page
•  Photographs should be as high in contrast as possible
•  Indicate the magniﬁ cation of photomicrographs in bar scales on the illustration itself instead of numerical 
magniﬁ cation factors
•  Make sure you use uniform lettering and sizing of your original artwork
•  Save text in illustrations as “graphics” or enclose the font
•  Only use the following fonts in your illustrations: Arial, Courier, Helvetica, Times, Symbol
•  Number the illustrations according to their sequence in the text
•  Use a logical naming convention for your artwork ﬁ les
•  Provide all illustrations as separate ﬁ les
•  Provide captions to illustrations separately
•  Produce images near to the desired size of the printed version
A detailed guide on electronic artwork is available on our website: 
http://www.elsevier.com/artwork instructions
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats
Regardless of the application used, when your electronic artwork is ﬁ nalised, please “save as” or convert 
the images to one of the following formats (Note the resolution requirements for line drawings, halftones, 
and line/halftone combinations given below.):
EPS: Vector drawings. Embed the font or save the text as “graphics”.
TIFF: Colour or greyscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (colour or greyscale): a minimum of 500 dpi is required.
DOC, XLS or PPT:  If your electronic artwork is created in any of these Microsoft Ofﬁ ce applications 
please supply “as is”.
Please do not:
•  Supply embedded graphics in your wordprocessor (spreadsheet, presentation) document
•  Supply ﬁ les that are optimised for screen use (like GIF, BMP, PICT, WPG); the resolution is too low
•  Supply ﬁ les that are too low in resolution
•  Submit graphics that are disproportionately large for the content
If, together with your accepted article, you submit usable colour ﬁ gures, Elsevier will ensure that these 
ﬁ gures will appear in colour completely free-of-charge in the electronic version of your paper, regardless 
of whether or not these illustrations are reproduced in colour in the printed version. Colour illustrations 
can only be included in print if the additional cost of reproduction (EUR 300 for the ﬁ rst page, and EUR 
200 for the second and subsequent pages) is contributed by the author: you will receive information 
regarding the costs from Elsevier after receipt of your accepted article. Please note that because of 
technical complications which may arise by converting colour ﬁ gures to ‘grey scale’ (for the printed 
version, should you not opt for colour in print), you should submit in addition usable black and white 
prints corresponding to all the colour illustrations.
Correspondence
 All contributions and all communications relating to the publication should be addressed to:
 Editor-in-Chief of Journal of Cardiology
 c/o Elsevier Japan, 1-9-15 Higashi-Azabu, Minato-ku, Tokyo 106-0044, Japan
 Fax: +81-3-3589-6366
 e-mail: jp.jjcc@elsevier.com
AUTHOR RIGHTS’
As an author you (or your employer or institution) may do the following:
-  make copies (print or electronic) of the article for your own personal use, including for your own class-
room teaching use
-  make copies and distribute such copies (including through e-mail) of the article to research colleagues, 
for the personal use by such colleagues (but not commercially or systematically, e.g., via an e-mail list 
or list server)
-  post a pre-print version of the article on Internet websites including electronic pre-print servers, and 
to retain indeﬁ nitely such version on such servers or sites
-  post a revised personal version of the ﬁ nal text of the article (to reﬂ ect changes made in the peer 
review and editing process) on your personal or institutional website or server, with a link to the journal 
homepage (on elsevier.com)
-  present the article at a meeting or conference and to distribute copies of the article to the delegates 
attending such a meeting
-  for your employer, if the article is a ‘work for hire’, made within the scope of your employment, your 
employer may use all or part of the information in the article for other intra-company use (e.g., training)
-  retain patent and trademark rights and rights to any processes or procedure described in the article
-  include the article in full or in part in a thesis or dissertation (provided that this is not to be published 
commercially)
-  use the article or any part thereof in a printed compilation of your works, such as collected writings or 
lecture notes (subsequent to publication of your article in the journal)
-  prepare other derivative works, to extend the article into book-length form, or to otherwise re-use 
portions or excerpts in other works, with full acknowledgement of its original publication in the journal
FUNDING BODY AGREEMENTS AND POLICIES
Elsevier has established agreements and developed policies to allow authors who publish in Elsevier 
journals to comply with potential manuscript archiving requirements as speciﬁ ed as conditions of their 
grant awards. To learn more about existing agreements and policies please visit http://www.elsevier.
com/fundingbodies
US National Institutes of Health (NIH) voluntary posting (“ Public Access”) policy
Elsevier facilitates author response to the NIH voluntary posting request (referred to as the NIH “Public 
Access Policy”; see http://publicaccess.nih.gov/) by posting the peer-reviewed author’s manuscript 
directly to PubMed Central on request from the author, 12 months after formal publication. Upon 
notiﬁ cation from Elsevier of acceptance, we will ask you to conﬁ rm via e-mail (by e-mailing us at 
NIHauthorrequest@elsevier.com) that your work has received NIH funding and that you intend to 
respond to the NIH policy request, along with your NIH award number to facilitate processing. Upon such 
conﬁ rmation, Elsevier will submit to PubMed Central on your behalf a version of your manuscript that will 
include peer-review comments, for posting 12 months after formal publication. This will ensure that you 
will have responded fully to the NIH request policy. There will be no need for you to post your manuscript 
directly with PubMed Central, and any such posting is prohibited.
PROOFS AND OFFPRINTS
Proofs will be sent to the corresponding author together with the offprint order form. If an e-mail address 
is supplied, proofs will be sent as e-mail attachment in PDF format, together with instructions. Authors 
are requested to return corrections by e-mail or fax within 48 hours. Authors will be charged for extensive 
alterations in the proofs. Twenty-ﬁ ve free offprints of each article will be supplied. Additional offprints 
can be ordered at the price shown on the offprint order form.
Journal of Cardiology does not have page charges.
